Stock comparison
BIOGEN INC. is 3.4x more valuable than Vaxcyte, Inc. by market capitalization ($29.37 B vs $8.64 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BIIB is larger
BIOGEN INC. is 3.4x more valuable than Vaxcyte, Inc. by market capitalization ($29.37 B vs $8.64 B).
Market value leader
BIIB
BIOGEN INC. is 3.4x more valuable than Vaxcyte, Inc. by market capitalization ($29.37 B vs $8.64 B).
Profit leader
BIIB
PCVX: -$766.63K vs BIIB: $1.29B.
| Metric | PCVX | BIIB |
|---|---|---|
| Market cap | $8.64 B | $29.37 B |
| US-listed rank | #1046 | #476 |
| Revenue (latest FY) | - | $9.89B |
| Net income (latest FY) | -$766.63K | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.7x |
| SEC filings | 681 | 2,690 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BIOGEN INC. is 3.4x more valuable than Vaxcyte, Inc. by market capitalization ($29.37 B vs $8.64 B).
Full pages: Vaxcyte, Inc. and BIOGEN INC., or browse the full rankings.